Home › Funds › Livforsakringsbolaget Skandia, Omsesidigt › NTRA
Livforsakringsbolaget Skandia, Omsesidigt position in NTRA
NATERA INC · Health Care
Livforsakringsbolaget Skandia, Omsesidigt reported holding 41,347 shares of NTRA (NATERA INC) in its Q3 2026 13F filing — a position valued at US$16.4M, representing 0.54% of its reported portfolio and ranking #38 among its reported holdings. Livforsakringsbolaget Skandia, Omsesidigt has disclosed NTRA holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Livforsakringsbolaget Skandia, Omsesidigt's NTRA position evolved
Livforsakringsbolaget Skandia, Omsesidigt first disclosed a stake in NTRA in Q1 2025 at 900 shares (US$127K). The position peaked in Q2 2026 at 45,547 shares, worth US$18.5M. Across 7 filings, Livforsakringsbolaget Skandia, Omsesidigt increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 41,347 shares valued at US$16.4M — a reduction of -4,200 shares quarter over quarter.. Notable position changes include a 788% increase in Q2 2025 (shares fell 5% over the following quarter), a 214% increase in Q3 2025 (shares rose 42% over the following quarter), a 396% increase in Q1 2026 (shares rose 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 900 | $127.27K | New |
| Q2 2025 | 8.00K | $791.16K | Add |
| Q3 2025 | 25.09K | $2.73M | Add |
| Q4 2025 | 9.11K | $1.01M | Reduce |
| Q1 2026 | 45.19K | $16.55M | Add |
| Q2 2026 | 45.55K | $18.49M | Add |
| Q3 2026 | 41.35K | $16.37M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NTRA and 13F data
NTRA (NATERA INC) is a Health Care company. 55 other funds we track also report a position in NTRA — the largest reported positions include Fidelity Management & Research (FMR) (US$5.65B), Duquesne Family Office LLC (US$864.9M), Castle Hook Partners LP (US$704.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NTRA
- Fidelity Management & Research (FMR) 13.68M sh · $5.65B · Q3 2026
- Duquesne Family Office LLC 3.19M sh · $864.92M · Q2 2026
- Castle Hook Partners LP 2.60M sh · $704.76M · Q2 2026
- Coatue Management 2.51M sh · $680.01M · Q2 2026
- COATUE MANAGEMENT LLC 2.51M sh · $680.01M · Q2 2026
- Farallon Capital Management 2.22M sh · $602.18M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 2.22M sh · $602.18M · Q2 2026
- FEDERATED HERMES, INC. 1.40M sh · $580.62M · Q3 2026
- FRED ALGER MANAGEMENT, LLC 1.78M sh · $482.64M · Q2 2026
- Sofinnova Investments, Inc. 1.55M sh · $420.82M · Q2 2026
- Maverick Capital 1.36M sh · $368.27M · Q2 2026
- MAVERICK CAPITAL LTD 1.36M sh · $368.27M · Q2 2026
More on Livforsakringsbolaget Skandia, Omsesidigt
FAQ
How long has Livforsakringsbolaget Skandia, Omsesidigt held NTRA?
Livforsakringsbolaget Skandia, Omsesidigt has disclosed NTRA holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is Livforsakringsbolaget Skandia, Omsesidigt's current position in NTRA?
As of Q3 2026, Livforsakringsbolaget Skandia, Omsesidigt holds 41.35K shares of NTRA (NATERA INC), valued at $16.37M, representing 0.54% of its reported portfolio and ranking #38.
Has Livforsakringsbolaget Skandia, Omsesidigt been buying or selling NTRA?
In the latest 13F filing (Q3 2026), Livforsakringsbolaget Skandia, Omsesidigt reduced its position in NTRA. The position peaked in Q2 2026 at 45.55K shares.
Which other funds hold NTRA?
Other major institutional holders of NTRA include Fidelity Management & Research (FMR), Duquesne Family Office LLC, Castle Hook Partners LP, among 55 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.